Principal Financial Group Inc Scholar Rock Holding Corp Transaction History

Principal Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$7.84 - $16.79 $92,433 - $197,954	11,790 New	11,790 $98,000
Q4 2021 Feb 09, 2022	SELL	$24.14 - $35.18 $161,327 - $235,107	-6,683 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$27.38 - $42.21 $29,652 - $45,713	-1,083 Reduced 13.95%	6,683 $221,000
Q2 2021 Aug 10, 2021	BUY	$26.34 - $46.62 $60,845 - $107,692	2,310 Added 42.34%	7,766 $224,000
Q1 2021 May 10, 2021	SELL	$45.96 - $68.02 $46,925 - $69,448	-1,021 Reduced 15.76%	5,456 $276,000
Q4 2020 Feb 08, 2021	BUY	$13.72 - $51.57 $88,864 - $334,018	6,477 New	6,477 $314,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.